- Home
- JMM vs IMRX Comparison
JMM vs IMRX Comparison
Compare JMM & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- IMRX
- Stock Information
- Founded
- JMM 1988
- IMRX 2008
- Country
- JMM United States
- IMRX United States
- Employees
- JMM N/A
- IMRX N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- JMM Finance
- IMRX Health Care
- Exchange
- JMM Nasdaq
- IMRX Nasdaq
- Market Cap
- JMM 56.8M
- IMRX 62.7M
- IPO Year
- JMM N/A
- IMRX 2021
- Fundamental
- Price
- JMM $5.98
- IMRX $2.02
- Analyst Decision
- JMM
- IMRX Buy
- Analyst Count
- JMM 0
- IMRX 7
- Target Price
- JMM N/A
- IMRX $12.80
- AVG Volume (30 Days)
- JMM 16.1K
- IMRX 4.9M
- Earning Date
- JMM 01-01-0001
- IMRX 02-28-2025
- Dividend Yield
- JMM 5.44%
- IMRX N/A
- EPS Growth
- JMM N/A
- IMRX N/A
- EPS
- JMM N/A
- IMRX N/A
- Revenue
- JMM N/A
- IMRX N/A
- Revenue This Year
- JMM N/A
- IMRX N/A
- Revenue Next Year
- JMM N/A
- IMRX N/A
- P/E Ratio
- JMM N/A
- IMRX N/A
- Revenue Growth
- JMM N/A
- IMRX N/A
- 52 Week Low
- JMM $5.29
- IMRX $1.00
- 52 Week High
- JMM $6.10
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- JMM 43.26
- IMRX 47.82
- Support Level
- JMM $5.97
- IMRX $1.84
- Resistance Level
- JMM $6.14
- IMRX $3.80
- Average True Range (ATR)
- JMM 0.08
- IMRX 0.29
- MACD
- JMM -0.00
- IMRX -0.03
- Stochastic Oscillator
- JMM 30.43
- IMRX 9.18
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.